Salix Pharmaceuticals Inc. v. Sandoz Canada Inc., 2026 FC 1288
Justice Furlanetto - 2026-10-27
Read full decision. Automatically generated summary:
By this motion, the Plaintiff Salix seeks to render certain paragraphs and documents in the Defendant, Sandoz, expert reports in chief inadmissible on the basis that they are not relevant to the current pleadings or are not relevant to the claims in issue. Salix asserts that they are an improper attempt to introduce new grounds and prior art into the proceeding that Sandoz strategically decided not to pursue by way of pleading amendment. ... For the reasons set out below, this motion is allowed in part and does not preclude Sandoz from taking formal steps to request amendment of their pleading where I have determined this is necessary to ground the impugned evidence, and where there may be circumstances supporting such a request under the appropriate factors to be considered. ... Like the [State of the Art], prior art that is being relied on as [Common General Knowledge] to support an obviousness allegation must be identified in the defendant’s pleading. ... on the basis that these impugned passages relate to a ground of overbreadth not alleged in the ASODCC – i.e., whether the inventor actually made and tested the claimed subject-matter of the claims. ... The facts disclosed in the impugned paragraphs of the Berg Expert Report are not directed at what the Patent disclosed but rather what the inventor did. They are not relevant to the claimed allegation. As such, the impugned paragraphs are not admissible based on the ASODCC. ... Should Sandoz wish to amend its ASODCC to support the impugned paragraphs and/or documents that have been found to be inadmissible, it may seek to do so. However, it will need to file a formal motion if the request is opposed and in doing so, address both Rule 75 and the legal test for amendment
Decision relates to:
- T-742-25 - SALIX PHARMACEUTICALS, INC. v. SANDOZ CANADA INC.